Medicines
Discover all available medicines and treatments
Discover all available medicines and treatments
Brand: Yttrium Y 90 Microspheres, TheraSphere, SIR-Spheres
Yttrium Y 90 is a radioactive isotope used in nuclear medicine for targeted radionuclide therapy. It emits beta radiation, which can destroy cancer cells. It is typically delivered via microspheres or conjugated to antibodies, allowing for localized treatment of tumors while minimizing damage to surrounding healthy tissues. Yttrium Y 90 is commonly used in the treatment of liver cancer and other cancers.
Treatment of certain cancers, particularly liver cancer, often via targeted radionuclide therapy.
Outcome:
Increased risk of bone marrow suppression
Mechanism:
Additive myelosuppressive effects
Outcome:
Increased risk of hypotension
Mechanism:
Additive hypotensive effects
Outcome:
Reduced absorption of other medications
Mechanism:
Changes in gastric pH
Most likely new formulation: Improved targeting methods using novel ligands or nanoparticles (2025, 70% confidence).
Based on increasing clinical trial data and adoption, Y-90 radioembolization is predicted to see a 15% increase in usage for liver cancer treatment over the next 5 years.
Radiopharmaceutical, Beta-emitter
Radioactive Isotope